Suppr超能文献

一种用于评估药物相互作用的半参数响应面模型。

A semiparametric response surface model for assessing drug interaction.

作者信息

Kong Maiying, Lee J Jack

机构信息

Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Unit 447, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

出版信息

Biometrics. 2008 Jun;64(2):396-405. doi: 10.1111/j.1541-0420.2007.00882.x. Epub 2007 Sep 26.

Abstract

When multiple drugs are administered simultaneously, investigators are often interested in assessing whether the drug combinations are synergistic, additive, or antagonistic. Existing response surface models are not adequate to capture the complex patterns of drug interactions. We propose a two-component semiparametric response surface model with a parametric function to describe the additive effect of a combination dose and a nonparametric function to capture the departure from the additive effect. The nonparametric function is estimated using the technique developed in thin plate splines, and the pointwise bootstrap confidence interval for this function is constructed. The proposed semiparametric model offers an effective way of formulating the additive effect while allowing the flexibility of modeling a departure from additivity. Example and simulations are given to illustrate that the proposed model provides an excellent estimation for different patterns of interactions between two drugs.

摘要

当同时使用多种药物时,研究人员通常有兴趣评估药物组合是协同、相加还是拮抗的。现有的响应面模型不足以捕捉药物相互作用的复杂模式。我们提出了一种双组分半参数响应面模型,该模型具有一个参数函数来描述联合剂量的相加效应,以及一个非参数函数来捕捉与相加效应的偏差。使用薄板样条中开发的技术估计非参数函数,并构建该函数的逐点自助置信区间。所提出的半参数模型提供了一种有效的方法来制定相加效应,同时允许对偏离相加性进行灵活建模。给出了实例和模拟,以说明所提出的模型为两种药物之间不同的相互作用模式提供了出色的估计。

相似文献

1
A semiparametric response surface model for assessing drug interaction.
Biometrics. 2008 Jun;64(2):396-405. doi: 10.1111/j.1541-0420.2007.00882.x. Epub 2007 Sep 26.
2
A generalized response surface model with varying relative potency for assessing drug interaction.
Biometrics. 2006 Dec;62(4):986-95. doi: 10.1111/j.1541-0420.2006.00579.x.
3
Dose-response curve estimation: a semiparametric mixture approach.
Biometrics. 2011 Dec;67(4):1543-54. doi: 10.1111/j.1541-0420.2011.01620.x. Epub 2011 May 31.
4
Applying Emax model and bivariate thin plate splines to assess drug interactions.
Front Biosci (Elite Ed). 2010 Jan 1;2(1):279-92. doi: 10.2741/e90.
5
Semiparametric frailty models for clustered failure time data.
Biometrics. 2012 Jun;68(2):429-36. doi: 10.1111/j.1541-0420.2011.01683.x. Epub 2011 Nov 9.
7
Design and analysis of drug combination experiments.
Biom J. 2005 Jun;47(3):299-308. doi: 10.1002/bimj.200410124.
9
A partially linear additive model for clustered proportion data.
Stat Med. 2018 Mar 15;37(6):1009-1030. doi: 10.1002/sim.7573. Epub 2017 Dec 15.
10
"Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data.
Biometrics. 2008 Jun;64(2):567-76. doi: 10.1111/j.1541-0420.2007.00928.x. Epub 2007 Oct 25.

引用本文的文献

2
Semiparametric estimation of the attributable fraction when there are interactions under monotonicity constraints.
BMC Med Res Methodol. 2020 Sep 21;20(1):236. doi: 10.1186/s12874-020-01118-4.
3
Drug Combinations: Mathematical Modeling and Networking Methods.
Pharmaceutics. 2019 May 2;11(5):208. doi: 10.3390/pharmaceutics11050208.
5
Monotonic single-index models to assess drug interactions.
Stat Med. 2017 Feb 20;36(4):655-670. doi: 10.1002/sim.7158. Epub 2016 Nov 2.
6
Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.
Curr Cancer Drug Targets. 2016;16(4):346-56. doi: 10.2174/1568009616666151207105851.
7
Assessing interactions for fixed-dose drug combinations in subcutaneous tumor xenograft studies.
Pharm Stat. 2013 May-Jun;12(3):115-9. doi: 10.1002/pst.1559. Epub 2013 Mar 7.
8
Assessing interactions for fixed-dose drug combinations in tumor xenograft studies.
J Biopharm Stat. 2012;22(3):535-43. doi: 10.1080/10543406.2011.556285.
9
Validation of a novel statistical model for assessing the synergy of combined-agent cancer chemoprevention.
Cancer Prev Res (Phila). 2010 Aug;3(8):917-28. doi: 10.1158/1940-6207.CAPR-10-0129. Epub 2010 Jul 27.
10
Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction.
Stat Biopharm Res. 2009 Feb 1;1(1):4-17. doi: 10.1198/sbr.2009.0001.

本文引用的文献

1
Interaction index and different methods for determining drug interaction in combination therapy.
J Biopharm Stat. 2007;17(3):461-80. doi: 10.1080/10543400701199593.
2
A generalized response surface model with varying relative potency for assessing drug interaction.
Biometrics. 2006 Dec;62(4):986-95. doi: 10.1111/j.1541-0420.2006.00579.x.
7
What is synergy?
Pharmacol Rev. 1989 Jun;41(2):93-141.
8
Evaluation of synergism or antagonism for the combined action of antiviral agents.
Antiviral Res. 1990 Jan;13(1):23-39. doi: 10.1016/0166-3542(90)90042-6.
9
A three-dimensional model to analyze drug-drug interactions.
Antiviral Res. 1990 Oct-Nov;14(4-5):181-205. doi: 10.1016/0166-3542(90)90001-n.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验